Grey Wolf Animal Health Corp

Grey Wolf Animal Health Corp has a market capitalization of CAD 53.8 million and a price-to-earnings ratio of 32.48, indicating a relatively high valuation compared to its earnings [doc:HA-latest]. The company's liquidity position is characterized by CAD 7.7 million in cash and equivalents, with a current ratio of 2.59, suggesting a strong ability to meet short-term obligations [doc:HA-latest]. However, the company's net cash position is negative after subtracting total debt, which is a key liquidity flag [doc:HA-latest]. In terms of profitability, Grey Wolf reports a return on equity of 5.42% and a return on assets of 2.57%, which are below the typical thresholds for strong performance in the retail sector [doc:HA-latest]. The company's operating margin is 11.34% (calculated from operating income of CAD 4.06 million on revenue of CAD 35.76 million), which is in line with the industry's median for specialty retailers [doc:HA-latest]. The gross margin of 53.3% (calculated from gross profit of CAD 19.06 million on revenue of CAD 35.76 million) is also in line with the industry median [doc:HA-latest]. The company's revenue is derived from two business units: Animal Health and Pharmacy. The Animal Health business unit focuses on selling, marketing, and distributing pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada [doc:HA-latest]. The Pharmacy business unit compounds pharmaceuticals for animal and human use based on prescriptions [doc:HA-latest]. The company's product categories include companion animals and equine health, with specific products such as SUCCEED Digestive Conditioning Program and SUCCEED Equine Fecal Blood Test [doc:HA-latest]. The geographic exposure is primarily within Canada, with no significant international operations disclosed [doc:HA-latest]. Grey Wolf's growth trajectory is reflected in its revenue of CAD 35.76 million, with no specific growth rate provided. The company's capital expenditure of CAD -519,110 indicates a reduction in capital spending, which may be a strategic decision to preserve cash [doc:HA-latest]. The company's free cash flow of CAD 3.84 million suggests that it is generating positive cash flow from operations after capital expenditures [doc:HA-latest]. The outlook for the current fiscal year is not explicitly provided, but the company's financial performance indicates a stable position [doc:HA-latest]. The risk assessment for Grey Wolf highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.83 is relatively low, indicating a conservative capital structure [doc:HA-latest]. The key risk flag is the negative net cash position after subtracting total debt, which could impact the company's ability to fund operations without additional financing [doc:HA-latest]. The company's dilution potential is low, with no significant dilution sources identified in the provided data [doc:HA-latest]. Recent events and filings for Grey Wolf include the latest financial snapshot, which provides an overview of the company's financial position as of the latest reporting period [doc:HA-latest]. No specific recent events or filings are detailed in the provided data, but the company's financial performance and risk profile suggest a stable but cautious outlook [doc:HA-latest].